Sweden's Orexo has announced it has bought the exclusive US rights to GAIA’s deprexis, a digital therapy to help patients manage their symptoms of depression and one of the most researched digital therapies in the world.
A new collaboration between Trinity Health and Orexo US aims to increase patient access to digital therapeutics to treat depression and alcohol abuse in North Dakota and Montana. Continue Reading By Mark Melchionna News 23 Aug 2022 mHealth App Utilization Did Not Improve Self-Measured Blood Pres...